Genetic Tumor Testing
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
A new program at Massachusetts General Hospital in Boston includes extracting the DNA from its cancer patients’ tumors to determine which abnormalities occur in the tumor cells, specific to the type of tumor. From these results, physicians hope to create better, targeted cancer therapies. Host Dr. Lee Freedman asks Dr. Leif Ellisen, associate professor of medicine at Harvard Medical School, about the details of this program. Will genetic tumor profiling be conducted at many more cancer centers in the near future?
Overview
A new program at Massachusetts General Hospital in Boston includes extracting the DNA from its cancer patients’ tumors to determine which abnormalities occur in the tumor cells, specific to the type of tumor. From these results, physicians hope to create better, targeted cancer therapies. Host Dr. Lee Freedman asks Dr. Leif Ellisen, associate professor of medicine at Harvard Medical School, about the details of this program. Will genetic tumor profiling be conducted at many more cancer centers in the near future?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
From Awareness to Action: What To Do With a Positive OSA Screen?
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
Collaborative Insights to Solve the Puzzle of Bladder Cancer
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?